Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Influenza Diagnostics Market: By Type: Traditional Diagnostic Test, Molecular Diagnostic Assay; By End Use: Hospital, Research Laboratory, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments
Global Influenza Diagnostics Market Outlook
The global influenza diagnostics market attained a value of USD 657 million in 2020. The influenza diagnostics market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 9% to reach USD 1103.3 million by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The influenza diagnostics market is being driven by the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of influenza.
Properties and Applications
Influenza diagnostics help determine if a person is suffering from influenza by detecting the influenza viral nucleoprotein antigen. These are commercially available and help provide results in as less as 30 minutes span, exhibiting colour change or other visual signals.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global influenza diagnostics market is segmented into types and end-uses.
The industry can be broadly categorised based on its types as:
- Traditional Diagnostic Test
- Molecular Diagnostic Assay
The traditional diagnostic test is further divided into rapid influenza diagnostic test (RIDT), viral culture, direct fluorescent antibody (DFA) test, and serological assay. The molecular diagnostic assay is subdivided into reverse transcription polymerase chain reaction (RT-PCR), nucleic acid sequence-based amplification (NASBA) test, loop-mediated isothermal amplification-based assay (LAMP), simple amplification-based assay (SAMBA), and other molecular diagnostic assays.
The industry can be divided based on its end-use into:
- Hospital
- Research Laboratory
- Others
The EMR report looks into the regional influenza diagnostics markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The influenza diagnostics market is being driven by the rising prevalence of influenza over the forecast period. The growing awareness among the population about the early diagnosis and effective treatment of influenza is aiding the market growth. It is also recommended for all patients with suspected influenza, thus, further enhancing the influenza diagnostics industry. The influenza diagnostics market is positively influenced by the rising funding for influenza diagnosis, research, and treatment. The disease can further degrade the health and develop complications in an individual, like pneumonia, bronchitis, asthma flare-ups, heart problems, and an ear infection, among others, creating an immediate need for influenza diagnostic and treatments, further propelling the influenza diagnostics market forward.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global influenza diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott Laboratories
- Becton, Dickinson and Company
- Coris BioConcept
- DiaSorin SpA
- F. Hoffmann-La Roche Ltd.
- Luminex Corporation
- Meridian Bioscience Inc.
- Quidel Corporation
- Sekisui Diagnostics
- Thermo Fisher Scientific Inc.
- Others
The EMR report gives an in-depth insight into the influenza diagnostics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, End Use, Region |
| Breakup by Type | Traditional Diagnostic Test, Molecular Diagnostic Assay |
| Breakup by End Use | Hospital, Research Laboratory, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Laboratories, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Influenza Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Influenza Diagnostics Historical Market (2017-2021)
8.3 Global Influenza Diagnostics Market Forecast (2022-2027)
8.4 Global Influenza Diagnostics Market by Type
8.4.1 Traditional Diagnostic Test
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.1.4 Breakup by Type
8.4.1.4.1 Rapid Influenza Diagnostic Test (RIDT)
8.4.1.4.2 Viral Culture
8.4.1.4.3 Direct Fluorescent Antibody (DFA) Test
8.4.1.4.4 Serological Assay
8.4.2 Molecular Diagnostic Assay
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.2.4 Breakup by Type
8.4.2.4.1 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
8.4.2.4.2 Nucleic Acid Sequence-Based Amplification (NASBA) Test
8.4.2.4.3 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
8.4.2.4.4 Simple Amplification-Based Assay (SAMBA)
8.4.2.4.5 Others
8.5 Global Influenza Diagnostics Market by End Use
8.5.1 Hospital
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Research Laboratory
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Others
8.6 Global Influenza Diagnostics Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Abbott Laboratories
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Coris BioConcept
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 DiaSorin SpA
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 F. Hoffmann-La Roche Ltd.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Luminex Corporation
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Meridian Bioscience Inc.
11.2.7.1 Company Overview
11.2.7.2 Product Portfolio
11.2.7.3 Demographic Reach and Achievements
11.2.7.4 Certifications
11.2.8 Quidel Corporation
11.2.8.1 Company Overview
11.2.8.2 Product Portfolio
11.2.8.3 Demographic Reach and Achievements
11.2.8.4 Certifications
11.2.9 Sekisui Diagnostics
11.2.9.1 Company Overview
11.2.9.2 Product Portfolio
11.2.9.3 Demographic Reach and Achievements
11.2.9.4 Certifications
11.2.10 Thermo Fisher Scientific Inc.
11.2.10.1 Company Overview
11.2.10.2 Product Portfolio
11.2.10.3 Demographic Reach and Achievements
11.2.10.4 Certifications
11.2.11 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Influenza Diagnostics Market: Key Industry Highlights, 2017 and 2027
2. Global Influenza Diagnostics Historical Market: Breakup by Type (USD Million), 2017-2021
3. Global Influenza Diagnostics Market Forecast: Breakup by Type (USD Million), 2022-2027
4. Global Influenza Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2021
5. Global Influenza Diagnostics Market Forecast: Breakup by End Use (USD Million), 2022-2027
6. Global Influenza Diagnostics Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global Influenza Diagnostics Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America Influenza Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America Influenza Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe Influenza Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe Influenza Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific Influenza Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific Influenza Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America Influenza Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America Influenza Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa Influenza Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa Influenza Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global Influenza Diagnostics Market Structure
Key Questions Answered in the Report
In 2020, the global influenza diagnostics market attained a value of nearly USD 657 million.
The market is projected to grow at a CAGR of 9% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 1103.3 million by 2026.
The major drivers of the industry, such as the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of the disease, are expected to aid the market growth.
The key market trend guiding the industry growth includes the rising funding for influenza diagnosis, research, and treatment.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Traditional diagnostic test and molecular diagnostic assay are the leading types of influenza diagnostics in the industry.
Hospital and research laboratory, among others, are the major end use segments of influenza diagnostics in the market.
The major players in the industry are Abbott Laboratories, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, and Thermo Fisher Scientific Inc., among others.
Analyst Review
The global influenza diagnostics market attained a value of USD 657 million in 2020, driven by the rising prevalence of influenza. Aided by the rise in research funding for influenza diagnostics, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 9%. The industry is projected to reach USD 1103.3 million by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the industry can be segmented into traditional diagnostic test and molecular diagnostic assay. On the basis of end uses, the industry can be divided into hospital, research laboratory, and others. The major regional markets for influenza diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, and Thermo Fisher Scientific Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global biochips based in-vitro diagnostics market has been driven by the growing number of applications of biochips in the historical period. Aided by the rising number of key players in the bioch...
The global cardiac biomarkers market attained a value of nearly USD 9.4 billion in 2021, driven by the increasing cases of critical heart conditions. Aided by the development of cardiac biomarker test...
The global cardiac troponin market has been driven by the increasing prevalence of acute coronary syndrome in the historical period. Aided by the increasing investments and rising demand for cardiac b...
The global gas chromatography market attained a value of nearly USD 2.92 billion in 2021, driven by the growing product demand in major end use industries, and rapid urbanisation. Aided by the growing...
The global B-hydroxybutyrate (ketone body) assay kits market is driven by the rising end uses of the product in hospitals and clinics. Aided by the growing R&D activities, the market is expected to wi...
NEWSLETTER